Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors-Reference-Cited by-同舟云学术

Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors

Published:2017-11-03 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Bhattacharyya Sagnik^ORCID,Egerton Alice,Kim Euitae,Rosso Lula,Riano Barros Daniela,Hammers Alexander^ORCID,Brammer Michael,Turkheimer Federico E.,Howes Oliver D.,McGuire Philip

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-14203-4.pdf

Reference79 articles.

1. UNODC. World Drug Report. (2010). http://www.unodc.org/documents/wdr/WDR_2010/World_Drug_Report_2010_lo-res.pdf .

2. Bhattacharyya, S., Crippa, J. A., Martin-Santos, R., Winton-Brown, T. & Fusar-Poli, P. Imaging the neural effects of cannabinoids: current status and future opportunities for psychopharmacology. Current pharmaceutical design 15, 2603–2614 (2009).

3. Bhattacharyya, S. et al. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology 35, 764–774, https://doi.org/10.1038/npp.2009.184 (2010).

4. Bhattacharyya, S. et al. Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of delta-9-tetrahydrocannabinol on midbrain and striatal function. Mol Psychiatry 17, 1152–1155, https://doi.org/10.1038/mp.2011.187 (2012).

5. D’Souza, D. C. et al. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 29, 1558–1572, https://doi.org/10.1038/sj.npp.1300496 (2004).

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A brief review of anandamide in cannabis use and cannabis use disorder;Anandamide in Health and Disease;2025

2. Effects of cannabidiol, with and without ∆9-tetrahydrocannabinol, on anxiety-like behavior following alcohol withdrawal in mice;Frontiers in Neuroscience;2024-06-18

3. A Multi-Level Analysis of Biological, Social, and Psychological Determinants of Substance Use Disorder and Co-Occurring Mental Health Outcomes;Psychoactives;2024-04-08

4. Vaporized D-limonene selectively mitigates the acute anxiogenic effects of Δ9-tetrahydrocannabinol in healthy adults who intermittently use cannabis;Drug and Alcohol Dependence;2024-04

5. Medicinal Cannabis and cannabinoids for the treatment of depression and anxiety: a literature review;Genetics and Molecular Research;2024